NUCLEAR MEDICINE COMMUNICATIONS, cilt.33, sa.4, ss.395-402, 2012 (SCI-Expanded, Scopus)
Introduction In this study we aimed to define the success of fluorine-18 (F-18) fluorodeoxyglucose (FDG) PET/computed tomography (PET/CT) in detecting recurrent disease in our patient group with colorectal cancer (CRC) and elevated carcinoembryonic antigen (CEA) levels.